¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ¼­¿ï´ëº´¿ø¾È°ú½ÉÆ÷Áö¾ö : 2024-03-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ¼­¿ï´ëº´¿ø¾È°ú½ÉÆ÷Áö¾ö : 2024-03-16
±³À°ÀÏÀÚ : 2024-03-16
±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø(¾î¸°À̺´¿ø)CJȦ ÇÏÀ̺긮µå(¿Â-¿ÀÇÁº´Çà)

±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà)_2024 ¼­¿ï´ëº´¿ø¾È°ú½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ¼­¿ï´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú

´ã´çÀÚ : ±è¹Ì°æ
¿¬¶ôó : 02-2072-2437

À̸ÞÀÏ : poong1016@snu.ac.kr

±³À°Á¾·ù : ¾È°ú, ±âŸ

Âü¼®¿¹»óÀÎ : 350¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í Àü¹®ÀÇ 6¸¸¿øÀü°øÀÇ 3¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 09:00~09:15 In vivo genome editing for IRD in SNUH GEC-GCT ±èÁ¤ÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 09:15~09:30 Vision restoration in a Retinitis Pigmentosa mouse model using Artificial Photoreceptor Proteins ÀӸżø(KIST)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 09:30~09:45 Seoul Artificial Retina Updates ¼­Á¾¸ð(¼­¿ï°ø´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 09:45~10:00 Recent advances in IRD: Era of Whole Genome Analysis ¿À¹é·Ï(Genome Insight)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:00~10:15 Somatic mutation profile in the aged retina and choroid ÁÖ±¤½Ä(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:15~10:30 Perivascular macrophages in the retina-from origin to function ±èÁ¾½Å(Æ÷Ç×°ø´ë)

ÈÞ½Ä 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:30~10:40 ÈÞ½Ä ()

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:40~10:55 Optimizing current management of diabetic macular edema ±è¿ë±Ô(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:55~11:10 Management of Diabetic retinoapthy: DRCR network update À¯³ª°æ(Áß¾Óº¸Èƺ´¿ø)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 11:10~11:25 Optimizing current and future treatment of neovascular AMD ±èÀçÈÖ(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 11:25~11:40 Non-exudative AMD and emerging treatment À±Ã¢±â(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 11:40~11:55 Updates on pachychoroidal spectrum diseases ¾ÈÁöÀ±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 11:55~12:25 State-of-the-Art Vitrectomy: Head-Up Surgery and Preoperative Evaluation with En Face Imaging Motohiro Kamei(Aichi Medical University)

½Ä»ç 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 12:25~13:25 Group photo & Lunch ()

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 13:25~13:40 Advances in refractory macular hole management  Áö¿µ¼®(Àü³²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 13:40~13:55 Surgical management of myopic traction maculopathy ¹Ú¿îö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 13:55~14:10 Management of pediatric retinal detachment ±è»óÁø(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 14:10~14:25 Advances in IOL fixation techniques º¯Àͼö(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 14:25~14:40 Optimizing 3D visualization system in retinal surgery »ç°ø¹Î(¿µ³²ÀÇ´ë)

ÈÞ½Ä 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 14:40~14:50 ÈÞ½Ä ()

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 14:50~15:05 Unveiling retinal disease using nationwide population-based study ¼Û¼öÁ¤(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 15:05~15:20 Real world practice and burden of retinal diseases based on Common Data Model ¹Ú»óÁØ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 15:20~15:35 Role of artificial intelligence in retinal imaging and diagnosis Á¶¹üÁÖ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 15:35~15:50 OCT-based deep learning model for macular degeneration Ȳ´öÁø(Çѱæ¾È°ú)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 15:50~16:05 Explainable AI and updated model in medical image diagnosis ÀÌÇü¿ì(°Ç±¹ÀÇ´ë)

ÈÞ½Ä 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 16:05~16:15 ÈÞ½Ä ()

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 16:15~16:30 Imaging and pathophysiology of central serous chorioretinopathy ¹éÁö¿ø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 16:30~16:45 Diagnosis and treatment of autoimmune retinopathy ¿ì¼¼ÁØ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 16:45~17:00 Pentosan polysulfate maculopathy ±è¹Î¼®(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 17:00~17:15 Challenges in the management of intraocular inflammation ¼ÛÁöÈÆ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 17:15~17:30 Advances in intraocular tumor management À̽±Ô(¿¬¼¼ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ¼­¿ï´ëº´¿ø¾È°ú½ÉÆ÷Áö¾ö : 2024-03-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦39ȸ ´ëÇÑ¿Ü°ú´ë»ç¿µ¾çÇÐȸ Çмú´ëȸ ¹× 2024 ±¹Á¦½ÉÆ÷Áö¾ö (2ÀÏÂ÷) : 2024-03-16
´ÙÀ½±Û ´ëÇÑôÃß¿Ü°úÇÐȸ 2024³â Á¦1Â÷ Àü°øÀǸ¦ À§ÇÑ Ã´Ãß ÀÔ¹® ¿¬¼ö°­Á : 2024-03-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 5 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 9 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 11 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 9 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 8 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 12 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 10 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 10 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 7 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 3 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 5 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 9 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 4 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 6 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 6 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷